Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(60 sites)
United States
Winship Cancer Institute of Emory University, Atlanta, Georgia University of Chicago Medical Center, Chicago, Illinois University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts